Ciprian Rezus

1 Independence Boulevard
Iasi, IS 700111, Romania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 78 publications

IL-6 in Systemic Lupus Erythematosus: At the Intersection of Disease Activity and Cardiovascular Risk.

IL-6 in Systemic Lupus Erythematosus: At the Intersection of Disease Activity and Cardiovascular Risk.

Journal: Journal of clinical medicine

Published: May 16, 2026

Progression to Radiographic Axial Spondyloarthritis: A Narrative Review on Timeline and Novel Prediction Factors.

Progression to Radiographic Axial Spondyloarthritis: A Narrative Review on Timeline and Novel Prediction Factors.

Journal: International journal of molecular sciences

Published: April 27, 2026

Coronary Artery Spasm in Patients with Type 2 Diabetes Mellitus.

Coronary Artery Spasm in Patients with Type 2 Diabetes Mellitus.

Journal: Life (Basel, Switzerland)

Published: January 15, 2026

Association of Inflammatory-Hematological Biomarkers with Hypertension and Related Comorbidities.

Association of Inflammatory-Hematological Biomarkers with Hypertension and Related Comorbidities.

Journal: Journal of clinical medicine

Published: December 29, 2025

Pathogenic and Clinical Relevance of Serum IL-17A and TNF-α in Systemic Lupus Erythematosus.

Pathogenic and Clinical Relevance of Serum IL-17A and TNF-α in Systemic Lupus Erythematosus.

Journal: International journal of molecular sciences

Published: October 08, 2025

Serum Interleukin-6 in Systemic Lupus Erythematosus: Insights into Immune Dysregulation, Disease Activity, and Clinical Manifestations.

Serum Interleukin-6 in Systemic Lupus Erythematosus: Insights into Immune Dysregulation, Disease Activity, and Clinical Manifestations.

Journal: Cells

Published: August 08, 2025

The Role of Galectin-3 as a Biomarker in the Cardio-Renal-Metabolic Pathology Axis.

The Role of Galectin-3 as a Biomarker in the Cardio-Renal-Metabolic Pathology Axis.

Journal: Journal of clinical medicine

Published: July 02, 2025

Cardiovascular Risk in Rheumatic Patients Treated with JAK Inhibitors: The Role of Traditional and Emerging Biomarkers in a Pilot Study.

Cardiovascular Risk in Rheumatic Patients Treated with JAK Inhibitors: The Role of Traditional and Emerging Biomarkers in a Pilot Study.

Journal: Journal of clinical medicine

Published: June 26, 2025

Effects of Janus Kinase Inhibitors on Cardio-Vascular Risk in Rheumatic Diseases: A Prospective Pilot Study.

Effects of Janus Kinase Inhibitors on Cardio-Vascular Risk in Rheumatic Diseases: A Prospective Pilot Study.

Journal: Journal of clinical medicine

Published: May 23, 2025

The Use of Direct Oral Anticoagulants (DOACs) in the Geriatric Population-How to Overcome the Challenges of Geriatric Syndromes.

The Use of Direct Oral Anticoagulants (DOACs) in the Geriatric Population-How to Overcome the Challenges of Geriatric Syndromes.

Journal: Journal of clinical medicine

Published: May 16, 2025

The Role of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Predicting Atrial Fibrillation and Its Comorbidities.

The Role of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Predicting Atrial Fibrillation and Its Comorbidities.

Journal: Life (Basel, Switzerland)

Published: May 02, 2025

IL-10 in Systemic Lupus Erythematosus: Balancing Immunoregulation and Autoimmunity.

IL-10 in Systemic Lupus Erythematosus: Balancing Immunoregulation and Autoimmunity.

Journal: International journal of molecular sciences

Published: March 07, 2025

Showing 1-12 of 78

Last Updated: 09/26/2026